Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

817 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rabies Virus Neutralizing Activity, Safety, and Immunogenicity of Recombinant Human Rabies Antibody Compared with Human Rabies Immunoglobulin in Healthy Adults.
Zhang JN, Meng YJ, Bai YH, Li YF, Yang LQ, Shi NM, Han HX, Gao J, Zhu LJ, Li SP, Zhang J, Zhao QH, Wang XQ, Wei JS, Ren LM, Cao CH, Chen C, Zhao W, Li L. Zhang JN, et al. Among authors: li yf, li sp, li l. Biomed Environ Sci. 2022 Sep 20;35(9):782-791. doi: 10.3967/bes2022.103. Biomed Environ Sci. 2022. PMID: 36189993 Free article. Clinical Trial.
[Safety analysis of 12 241 infants inoculated in three sites of diphtheria, tetanus, acellular pertussis and haemophilus influenzae type b combined vaccine in Chaoyang District of Beijing].
Bai YH, Li SP, Ding S, Lu Q, Yang LQ, Zhang YL, Zhang JN, Li L, Zhang Z. Bai YH, et al. Among authors: li sp, li l. Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Sep 6;54(9):953-957. doi: 10.3760/cma.j.cn112150-20200316-00342. Zhonghua Yu Fang Yi Xue Za Zhi. 2020. PMID: 32907284 Chinese.
Neutralizing antibody activity, safety and immunogenicity of human anti-rabies virus monoclonal antibody (Ormutivimab) in Chinese healthy adults: A phase Ⅱb randomized, double-blind, parallel-controlled study.
Li L, Li Y, Bai Y, Li G, Zhang J, Yang L, Zhao W, Zhao W, Luo F, Zhao Q, Zhang Z, Liu Y, Li S, Lu Q, Wang H, Zhang J, Zhang Y, Gao J, Shi N. Li L, et al. Vaccine. 2022 Oct 6;40(42):6153-6162. doi: 10.1016/j.vaccine.2022.09.022. Epub 2022 Sep 16. Vaccine. 2022. PMID: 36123259 Free article. Clinical Trial.
Safety and Viral Shedding of Live Attenuated Influenza Vaccine (LAIV) in Chinese Healthy Juveniles and Adults: A Phase Ⅰ Randomized, Double-Blind, Placebo-Controlled Study.
Li L, Shi N, Xu N, Wang H, Zhao H, Xu H, Liu D, Zhang Z, Li S, Zhang J, Guo C, Huo J, Zhao M, Luo F, Yang L, Bai Y, Lu Q, Zhang Y, Zhong Y, Gao W. Li L, et al. Vaccines (Basel). 2022 Oct 26;10(11):1796. doi: 10.3390/vaccines10111796. Vaccines (Basel). 2022. PMID: 36366310 Free PMC article.
Immunogenicity and immune persistence of Zagreb 2-1-1 regimen of rabies vaccine in Chinese healthy individuals: A randomized, parallel-controlled of homologous vaccine with different immune procedure study.
Li L, Xu J, Zhang J, Wang F, Cai J, Yang L, Zhu Z, Bai Y, Jia B, Ma J, Shi N, Li S. Li L, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2403177. doi: 10.1080/21645515.2024.2403177. Epub 2024 Oct 2. Hum Vaccin Immunother. 2024. PMID: 39358206 Free PMC article. Clinical Trial.
817 results